David Zaccardelli, President and CEO at Verona Pharma plc (VRNA), sold 144,816 shares at $4.38 ($634K) on 2024-10-24, disclosed to the SEC on 2024-10-25.
Scheduled sale ($634k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.38 | 16 | $70 | 0.0% |
| 2 | $4.38 | 140,000 | $613K | 96.7% |
| 3 | $4.38 | 4,800 | $21K | 3.3% |
| Total | $4.38 avg | 144,816 | $634K | 100% |
| Filing → |
| VRNA | SELL | 2025-05-29 | $7.1M | — | Filing → |
| VRNA | SELL | 2025-05-05 | $7.0M | — | Filing → |
| VRNA | SELL | 2025-05-01 | $1.6M | — | Filing → |